Vital health parameters of the 2 volunteers, who are administered the Oxford COVID-19 vaccine candidate at a medical college here as a part of the clinical test |phase II|clinical trial|clinical test”> phase II clinical trial clinical trial, are normal, a senior official from the medical facility said on Thursday.
Two men, aged 32 and 48, got the primary shot of the ‘Covishield’ vaccine, being manufactured by Pune-based Serum Institute of India (SII), at Bharti Vidyapeeth’s Medical College and Hospital on Wednesday. The dose are going to be repeated after one month, a politician said.
“Since yesterday, our medical team is in-tuned with the 2 volunteers and both are fine. they are doing not have any pain, fever, injection-side reaction or systemic illness post-vaccination,” the medical college and hospital’s deputy medical director Dr Jitendra Oswal said.
After the vaccine was administered on Wednesday, both the volunteers were observed for half-hour and later allowed to travel home, he said.
“They are given all the required emergency numbers (to contact just in case of need) and our medical team is additionally conducting follow-ups with them,” he added.
The vaccine dose are going to be repeated on both the volunteers after one month, the hospital’s medical director Dr Sanjay Lalwani said on Wednesday.
He said altogether , 25 candidates are going to be given the vaccine within the next seven days.
Dr Sonali Palkar, in-charge of the medical college’s research cell, said four to 5 persons were screened on Wednesday and a choice to administer the vaccine to them as a part of the clinical test is subject to their COVID-19 and antibody test reports.
